The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
September 12th 2024
In an interview, lead investigator Lauren Moran, MD, shared how the results inform clinical practice on safe amphetamine dosing.
September 12th 2024
ADHD Drug Also Produces Promising Results in Adults with Binge Eating Disorder
May 7th 2014Adult patients with binge eating disorder who were treated for 12 weeks with lisdexamfetamine dimesylate reported having 4 fewer binge days per week, and also experienced improvements in weight and triglyceride levels.
Executive Function Disorder and ADHD
November 17th 2013Executive function disorder and ADHD share several overlapping symptoms, and the presence of executive function impairment is often associated with a diagnosis of ADHD. Clinicians should be aware of the testing modalities that can help accurately identify executive function disorder, and also be aware of the limitations of current medications when it comes to mitigating symptoms.
DEA, Drug Companies Trade Blame for Generic ADHD Drug Shortage
January 4th 2012A widespread shortage of generic drugs in recent months has made life increasingly difficult for patients with ADHD, and many are growing frantic as they are forced to purchase costly brand name drugs instead of scarce generic versions.
No Link Found Between ADHD Drugs and Cardiovascular Events in Adults
December 22nd 2011A study involving more than 150,000 adult users of attention deficit hyperactivity disorder drugs has found no evidence of a link between the medications and increased risk of heart attack, stroke, or sudden cardiac death.
Different Subtypes of ADHD Call for Individualized Treatment
November 21st 2011According to new research focused primarily on the differences and similarities between the two most common subtypes of attention deficit-hyperactivity disorder (ADHD) subtypes-ADHD-PI and ADHD-C-children with the neurological disorder could greatly benefit from individualized assessment and treatment, which means there may soon be a call to change ADHD guidelines.
AAP 2011: Speaking with Dr. Natasha Gerbert [Video]
One of the great thing about covering a medical conference is being able to interact with physicians and thought leaders about the hot topics in their specialty. In this video, Natasha Bergert, MD, a pediatrician from Kansas City, MO, discusses her experience at this year's AAP conference.